Delta-Fly Pharma Inc. (4598)
Market Closed
2 Oct, 06:00 AM
JPX JPX Primary ¥
111. 00
-4
-3.4783%
¥
6.72B Market Cap
- P/E Ratio
- Div Yield
383,400 Volume
- Eps
¥ 115
Previous Close Want to track 4598 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Delta-Fly Pharma Inc. (4598) Statistics
Valuation metrics
Market Cap 6.72B
Enterprise value 1.11B
Trailing P/E (ttm) -0.62
Forward P/E -9.08
PEG ratio -0.02
Price/Sales (ttm) -
Price/Book (mrq) -5.99
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.67
Overview
Shares outstanding 11.52M
Float 10.21M
Shares short -
% Held by insiders 0.16%
% Held by institutions 0.07%
Average volume (10 days) 328.47K
Average volume (90 days) 1.33M
Price summary
52-Week low 92
52-Week high 700
Beta -0.7
50-Day moving average 116.74
200-Day moving average 141.46
Financials
Fiscal year
Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 31 Mar 2024
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -11.17%
Return on equity -16.78%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -1.65B
Net income to common (ttm) -1.66B
Diluted EPS (ttm) -120.22
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 240M
Total cash per share (mrq) 5.96
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 0.32%
Book value per share (mrq) -14.01
Cash Flow
Cash flow statement -1.75B
Levered free cash flow (LFCF) -1.72B
2026 © Marketlog. All Rights Reserved.
